• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RCE 0.97% 52.0¢

RECCE PHARMACEUTICALS LTD - Announcements

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce... An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.More

Corporate Spotlight

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight arrow Created with Sketch.

RCE receives grant from US Department of Defence

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

RCE Trading HaltPRICE SENSITIVE06/02/19 download Created with Sketch. 272.95KB
RCE Appendix 4C and commentaryPRICE SENSITIVE31/01/19 download Created with Sketch. 672.92KB
RCE R&D Incentive Rebate ReceivedPRICE SENSITIVE31/01/19 download Created with Sketch. 218.33KB
RCE Funding UpdatePRICE SENSITIVE18/01/19 download Created with Sketch. 205.25KB
RCE Funding Update16/01/19 download Created with Sketch. 202.72KB
RCE Funding UpdatePRICE SENSITIVE18/12/18 download Created with Sketch. 203.36KB
RCE Company Constitution03/12/18 download Created with Sketch. 583.36KB
RCE Results of Meeting29/11/18 download Created with Sketch. 271.94KB
RCE Funding UpdatePRICE SENSITIVE23/11/18 download Created with Sketch. 261.78KB
RCE Investor Presentation21/11/18 download Created with Sketch. 4.59MB
RCE Appendix 4C and commentaryPRICE SENSITIVE01/11/18 download Created with Sketch. 336.62KB
RCE Notice of General Meeting/Proxy Form29/10/18 download Created with Sketch. 1.29MB
RCE Recce Meets Antibiotic Leaders to Explore Opportunities25/10/18 download Created with Sketch. 1.95MB
RCE Date of 2018 Annual General Meeting08/10/18 download Created with Sketch. 118.09KB
RCE R&D Incentive Rebate ReceivedPRICE SENSITIVE02/10/18 download Created with Sketch. 355.26KB
RCE Appendix 4G28/09/18 download Created with Sketch. 100.09KB
RCE 2018 Annual Report28/09/18 download Created with Sketch. 7.41MB
RCE Change of Registry Address: Automic P/L - Sydney Office28/09/18 download Created with Sketch. 91.41KB
RCE Funding UpdatePRICE SENSITIVE13/09/18 download Created with Sketch. 191.19KB
RCE Investor Presentation12/09/18 download Created with Sketch. 1.22MB
RCE Investor Presentation04/09/18 download Created with Sketch. 1.14MB
RCE Appendix 4E - Preliminary Final ReportPRICE SENSITIVE31/08/18 download Created with Sketch. 254.44KB
RCE Key Australian Patent for Recce's Broad-Spectrum AntibioticsPRICE SENSITIVE31/07/18 download Created with Sketch. 427.82KB
RCE Appendix 4C and commentaryPRICE SENSITIVE30/07/18 download Created with Sketch. 968.99KB
RCE Update on Progress of Broad Spectrum Antibiotic RECCE 327PRICE SENSITIVE17/07/18 download Created with Sketch. 180.48KB
RCE Change of Share Registry16/07/18 download Created with Sketch. 118.78KB
RCE Recce Presented at FNN/Shaw and Partners Investor Conference21/06/18 download Created with Sketch. 321.34KB
RCE Update on meeting with US FDAPRICE SENSITIVE05/06/18 download Created with Sketch. 520.35KB
RCE Investor Presentation05/06/18 download Created with Sketch. 2.3MB
RCE Recce Pharmaceuticals to Present at Investor Conference30/05/18 download Created with Sketch. 135.61KB
RCE Update on meeting with US FDA16/05/18 download Created with Sketch. 182.04KB
RCE Cleansing Statement01/05/18 download Created with Sketch. 128.62KB
RCE Appendix 3B01/05/18 download Created with Sketch. 156.51KB
RCE Appendix 4C and commentaryPRICE SENSITIVE30/04/18 download Created with Sketch. 209.11KB
RCE Initial Director's Interest Notice27/04/18 download Created with Sketch. 29.71KB
RCE Pharmaceutical Expert Joins Board of Directors24/04/18 download Created with Sketch. 189.65KB
RCE Additional AU$861,590 R&D Tax Incentive Rebate ReceivedPRICE SENSITIVE23/04/18 download Created with Sketch. 194.32KB
RCE RECCE Antibiotic International Media Attention19/04/18 download Created with Sketch. 191.83KB
RCE April Funding Update28/03/18 download Created with Sketch. 188.81KB
RCE Meeting with US FDA on Phase I Clinical Trial for RECCE 32708/03/18 download Created with Sketch. 188.63KB
RCE Recce Half Yearly Report and Appendix 4DPRICE SENSITIVE28/02/18 download Created with Sketch. 222.52KB
RCE Cleansing Statement16/02/18 download Created with Sketch. 128.63KB
RCE Appendix 3B16/02/18 download Created with Sketch. 158.72KB
RCE Results of Meeting16/02/18 download Created with Sketch. 283.82KB
RCE Data Submission & Further Communication Request with US FDAPRICE SENSITIVE15/02/18 download Created with Sketch. 187.98KB
RCE Investor Presentation31/01/18 download Created with Sketch. 2.6MB
RCE Appendix 4C and commentaryPRICE SENSITIVE31/01/18 download Created with Sketch. 203.09KB
RCE Recce to present at two investor conferences25/01/18 download Created with Sketch. 148.66KB
RCE Notice of General Meeting/Proxy Form17/01/18 download Created with Sketch. 548.34KB
RCE Cleansing Statement17/01/18 download Created with Sketch. 128.65KB
RCE Appendix 3B17/01/18 download Created with Sketch. 158.57KB
RCE Appendix 3B15/01/18 download Created with Sketch. 152.08KB
RCE AusIndustry Awards Recce Financial SupportPRICE SENSITIVE15/01/18 download Created with Sketch. 300.59KB
RCE Shares to be released from Escrow10/01/18 download Created with Sketch. 125.82KB
RCE Broker Presentation11/12/17 download Created with Sketch. 1.87MB
RCE Cleansing Statement04/12/17 download Created with Sketch. 128.56KB
RCE Appendix 3B04/12/17 download Created with Sketch. 158.72KB
RCE Company Secretary Appointment/Resignation29/11/17 download Created with Sketch. 207.83KB
RCE Results of Meeting21/11/17 download Created with Sketch. 277.26KB
RCE 2017 AGM Presentation21/11/17 download Created with Sketch. 819.39KB
RCE US FDA Grants Qualified Infectious Disease Product DesignatiPRICE SENSITIVE16/11/17 download Created with Sketch. 279.16KB
RCE Trading Halt Request14/11/17 download Created with Sketch. 211.05KB
RCE Trading HaltPRICE SENSITIVE14/11/17 download Created with Sketch. 251.91KB
RCE Change in Sydney Office Address08/11/17 download Created with Sketch. 203.7KB
RCE Cleansing Statement03/11/17 download Created with Sketch. 78.81KB
RCE Appendix 3B03/11/17 download Created with Sketch. 568.49KB
RCE Appendix 4C - quarterlyPRICE SENSITIVE31/10/17 download Created with Sketch. 211.6KB
RCE Change in substantial holding25/10/17 download Created with Sketch. 1.64MB
RCE Appendix 3B25/10/17 download Created with Sketch. 566.36KB
RCE Successful Share Purchase Plan23/10/17 download Created with Sketch. 244.96KB
RCE Notice of Annual General Meeting/Proxy Form20/10/17 download Created with Sketch. 608.16KB
RCE Appendix 4G20/10/17 download Created with Sketch. 255.61KB
RCE Annual Report to shareholders20/10/17 download Created with Sketch. 4.39MB
RCE Cleansing Statement03/10/17 download Created with Sketch. 78.82KB
RCE Appendix 3B03/10/17 download Created with Sketch. 569.1KB
RCE Recce Launches Share Purchase PlanPRICE SENSITIVE27/09/17 download Created with Sketch. 464.2KB
RCE Correction to Appendix 3B26/09/17 download Created with Sketch. 449.06KB
RCE Cleansing Statement25/09/17 download Created with Sketch. 78.82KB
RCE Appendix 3B25/09/17 download Created with Sketch. 297.11KB
RCE Response to ASX Price QueryPRICE SENSITIVE18/09/17 download Created with Sketch. 612.45KB
RCE Investor Presention15/09/17 download Created with Sketch. 1.64MB
RCE Cleansing Statement07/09/17 download Created with Sketch. 78.82KB
RCE Appendix 3B07/09/17 download Created with Sketch. 335.73KB
RCE Recce Confirms Pre-IND Data Submission to US FDAPRICE SENSITIVE07/09/17 download Created with Sketch. 244.64KB
RCE Appendix 4E and Financial ReportPRICE SENSITIVE01/09/17 download Created with Sketch. 1.46MB
RCE Appendix 4C - quarterlyPRICE SENSITIVE31/07/17 download Created with Sketch. 212.83KB
RCE Recce Confirms Delivery by Intravenous DripPRICE SENSITIVE31/07/17 download Created with Sketch. 800.89KB
RCE Cleansing Statement20/07/17 download Created with Sketch. 78.81KB
RCE Appendix 3B20/07/17 download Created with Sketch. 335.13KB
RCE Recce achieves milestone with volume productionPRICE SENSITIVE20/07/17 download Created with Sketch. 336.66KB
RCE Cleansing Statement22/06/17 download Created with Sketch. 78.75KB
RCE Appendix 3B22/06/17 download Created with Sketch. 426.06KB
RCE Recce constructs automated manufacturing facility to supportPRICE SENSITIVE22/06/17 download Created with Sketch. 335.97KB
RCE Recce secures up to A$6.05 million investment agreement withPRICE SENSITIVE16/06/17 download Created with Sketch. 326.06KB
RCE Recce moves closer to clinical study applicationPRICE SENSITIVE19/05/17 download Created with Sketch. 337.1KB
RCE Appendic 4G16/05/17 download Created with Sketch. 253.55KB
RCE Appendix 4C - quarterlyPRICE SENSITIVE28/04/17 download Created with Sketch. 210.77KB
RCE Recce calls for Australian investment in R&D to develop new19/04/17 download Created with Sketch. 325.49KB
RCE Operational UpdatePRICE SENSITIVE10/04/17 download Created with Sketch. 1MB
RCE Data from large animal study shows RECCE 327 well toleratedPRICE SENSITIVE27/03/17 download Created with Sketch. 198.96KB
RCE Trading Halt
06/02/19PRICE SENSITIVE download Created with Sketch. 272.95KB
RCE Appendix 4C and commentary
31/01/19PRICE SENSITIVE download Created with Sketch. 672.92KB
RCE R&D Incentive Rebate Received
31/01/19PRICE SENSITIVE download Created with Sketch. 218.33KB
RCE Funding Update
18/01/19PRICE SENSITIVE download Created with Sketch. 205.25KB
RCE Funding Update
16/01/19 download Created with Sketch. 202.72KB
RCE Funding Update
18/12/18PRICE SENSITIVE download Created with Sketch. 203.36KB
RCE Company Constitution
03/12/18 download Created with Sketch. 583.36KB
RCE Results of Meeting
29/11/18 download Created with Sketch. 271.94KB
RCE Funding Update
23/11/18PRICE SENSITIVE download Created with Sketch. 261.78KB
RCE Investor Presentation
21/11/18 download Created with Sketch. 4.59MB
RCE Appendix 4C and commentary
01/11/18PRICE SENSITIVE download Created with Sketch. 336.62KB
RCE Notice of General Meeting/Proxy Form
29/10/18 download Created with Sketch. 1.29MB
RCE Recce Meets Antibiotic Leaders to Explore Opportunities
25/10/18 download Created with Sketch. 1.95MB
RCE Date of 2018 Annual General Meeting
08/10/18 download Created with Sketch. 118.09KB
RCE R&D Incentive Rebate Received
02/10/18PRICE SENSITIVE download Created with Sketch. 355.26KB
RCE Appendix 4G
28/09/18 download Created with Sketch. 100.09KB
RCE 2018 Annual Report
28/09/18 download Created with Sketch. 7.41MB
RCE Change of Registry Address: Automic P/L - Sydney Office
28/09/18 download Created with Sketch. 91.41KB
RCE Funding Update
13/09/18PRICE SENSITIVE download Created with Sketch. 191.19KB
RCE Investor Presentation
12/09/18 download Created with Sketch. 1.22MB
RCE Investor Presentation
04/09/18 download Created with Sketch. 1.14MB
RCE Appendix 4E - Preliminary Final Report
31/08/18PRICE SENSITIVE download Created with Sketch. 254.44KB
RCE Key Australian Patent for Recce's Broad-Spectrum Antibiotics
31/07/18PRICE SENSITIVE download Created with Sketch. 427.82KB
RCE Appendix 4C and commentary
30/07/18PRICE SENSITIVE download Created with Sketch. 968.99KB
RCE Update on Progress of Broad Spectrum Antibiotic RECCE 327
17/07/18PRICE SENSITIVE download Created with Sketch. 180.48KB
RCE Change of Share Registry
16/07/18 download Created with Sketch. 118.78KB
RCE Recce Presented at FNN/Shaw and Partners Investor Conference
21/06/18 download Created with Sketch. 321.34KB
RCE Update on meeting with US FDA
05/06/18PRICE SENSITIVE download Created with Sketch. 520.35KB
RCE Investor Presentation
05/06/18 download Created with Sketch. 2.3MB
RCE Recce Pharmaceuticals to Present at Investor Conference
30/05/18 download Created with Sketch. 135.61KB
RCE Update on meeting with US FDA
16/05/18 download Created with Sketch. 182.04KB
RCE Cleansing Statement
01/05/18 download Created with Sketch. 128.62KB
RCE Appendix 3B
01/05/18 download Created with Sketch. 156.51KB
RCE Appendix 4C and commentary
30/04/18PRICE SENSITIVE download Created with Sketch. 209.11KB
RCE Initial Director's Interest Notice
27/04/18 download Created with Sketch. 29.71KB
RCE Pharmaceutical Expert Joins Board of Directors
24/04/18 download Created with Sketch. 189.65KB
RCE Additional AU$861,590 R&D Tax Incentive Rebate Received
23/04/18PRICE SENSITIVE download Created with Sketch. 194.32KB
RCE RECCE Antibiotic International Media Attention
19/04/18 download Created with Sketch. 191.83KB
RCE April Funding Update
28/03/18 download Created with Sketch. 188.81KB
RCE Meeting with US FDA on Phase I Clinical Trial for RECCE 327
08/03/18 download Created with Sketch. 188.63KB
RCE Recce Half Yearly Report and Appendix 4D
28/02/18PRICE SENSITIVE download Created with Sketch. 222.52KB
RCE Cleansing Statement
16/02/18 download Created with Sketch. 128.63KB
RCE Appendix 3B
16/02/18 download Created with Sketch. 158.72KB
RCE Results of Meeting
16/02/18 download Created with Sketch. 283.82KB
RCE Data Submission & Further Communication Request with US FDA
15/02/18PRICE SENSITIVE download Created with Sketch. 187.98KB
RCE Investor Presentation
31/01/18 download Created with Sketch. 2.6MB
RCE Appendix 4C and commentary
31/01/18PRICE SENSITIVE download Created with Sketch. 203.09KB
RCE Recce to present at two investor conferences
25/01/18 download Created with Sketch. 148.66KB
RCE Notice of General Meeting/Proxy Form
17/01/18 download Created with Sketch. 548.34KB
RCE Cleansing Statement
17/01/18 download Created with Sketch. 128.65KB
RCE Appendix 3B
17/01/18 download Created with Sketch. 158.57KB
RCE Appendix 3B
15/01/18 download Created with Sketch. 152.08KB
RCE AusIndustry Awards Recce Financial Support
15/01/18PRICE SENSITIVE download Created with Sketch. 300.59KB
RCE Shares to be released from Escrow
10/01/18 download Created with Sketch. 125.82KB
RCE Broker Presentation
11/12/17 download Created with Sketch. 1.87MB
RCE Cleansing Statement
04/12/17 download Created with Sketch. 128.56KB
RCE Appendix 3B
04/12/17 download Created with Sketch. 158.72KB
RCE Company Secretary Appointment/Resignation
29/11/17 download Created with Sketch. 207.83KB
RCE Results of Meeting
21/11/17 download Created with Sketch. 277.26KB
RCE 2017 AGM Presentation
21/11/17 download Created with Sketch. 819.39KB
RCE US FDA Grants Qualified Infectious Disease Product Designati
16/11/17PRICE SENSITIVE download Created with Sketch. 279.16KB
RCE Trading Halt Request
14/11/17 download Created with Sketch. 211.05KB
RCE Trading Halt
14/11/17PRICE SENSITIVE download Created with Sketch. 251.91KB
RCE Change in Sydney Office Address
08/11/17 download Created with Sketch. 203.7KB
RCE Cleansing Statement
03/11/17 download Created with Sketch. 78.81KB
RCE Appendix 3B
03/11/17 download Created with Sketch. 568.49KB
RCE Appendix 4C - quarterly
31/10/17PRICE SENSITIVE download Created with Sketch. 211.6KB
RCE Change in substantial holding
25/10/17 download Created with Sketch. 1.64MB
RCE Appendix 3B
25/10/17 download Created with Sketch. 566.36KB
RCE Successful Share Purchase Plan
23/10/17 download Created with Sketch. 244.96KB
RCE Notice of Annual General Meeting/Proxy Form
20/10/17 download Created with Sketch. 608.16KB
RCE Appendix 4G
20/10/17 download Created with Sketch. 255.61KB
RCE Annual Report to shareholders
20/10/17 download Created with Sketch. 4.39MB
RCE Cleansing Statement
03/10/17 download Created with Sketch. 78.82KB
RCE Appendix 3B
03/10/17 download Created with Sketch. 569.1KB
RCE Recce Launches Share Purchase Plan
27/09/17PRICE SENSITIVE download Created with Sketch. 464.2KB
RCE Correction to Appendix 3B
26/09/17 download Created with Sketch. 449.06KB
RCE Cleansing Statement
25/09/17 download Created with Sketch. 78.82KB
RCE Appendix 3B
25/09/17 download Created with Sketch. 297.11KB
RCE Response to ASX Price Query
18/09/17PRICE SENSITIVE download Created with Sketch. 612.45KB
RCE Investor Presention
15/09/17 download Created with Sketch. 1.64MB
RCE Cleansing Statement
07/09/17 download Created with Sketch. 78.82KB
RCE Appendix 3B
07/09/17 download Created with Sketch. 335.73KB
RCE Recce Confirms Pre-IND Data Submission to US FDA
07/09/17PRICE SENSITIVE download Created with Sketch. 244.64KB
RCE Appendix 4E and Financial Report
01/09/17PRICE SENSITIVE download Created with Sketch. 1.46MB
RCE Appendix 4C - quarterly
31/07/17PRICE SENSITIVE download Created with Sketch. 212.83KB
RCE Recce Confirms Delivery by Intravenous Drip
31/07/17PRICE SENSITIVE download Created with Sketch. 800.89KB
RCE Cleansing Statement
20/07/17 download Created with Sketch. 78.81KB
RCE Appendix 3B
20/07/17 download Created with Sketch. 335.13KB
RCE Recce achieves milestone with volume production
20/07/17PRICE SENSITIVE download Created with Sketch. 336.66KB
RCE Cleansing Statement
22/06/17 download Created with Sketch. 78.75KB
RCE Appendix 3B
22/06/17 download Created with Sketch. 426.06KB
RCE Recce constructs automated manufacturing facility to support
22/06/17PRICE SENSITIVE download Created with Sketch. 335.97KB
RCE Recce secures up to A$6.05 million investment agreement with
16/06/17PRICE SENSITIVE download Created with Sketch. 326.06KB
RCE Recce moves closer to clinical study application
19/05/17PRICE SENSITIVE download Created with Sketch. 337.1KB
RCE Appendic 4G
16/05/17 download Created with Sketch. 253.55KB
RCE Appendix 4C - quarterly
28/04/17PRICE SENSITIVE download Created with Sketch. 210.77KB
RCE Recce calls for Australian investment in R&D to develop new
19/04/17 download Created with Sketch. 325.49KB
RCE Operational Update
10/04/17PRICE SENSITIVE download Created with Sketch. 1MB
RCE Data from large animal study shows RECCE 327 well tolerated
27/03/17PRICE SENSITIVE download Created with Sketch. 198.96KB
(20min delay)
Last
52.0¢
Change
0.005(0.97%)
Mkt cap ! $120.5M
Open High Low Value Volume
54.0¢ 54.0¢ 52.0¢ $4.485K 8.497K

Buyers (Bids)

No. Vol. Price($)
1 17 52.0¢
 

Sellers (Offers)

Price($) Vol. No.
53.0¢ 14897 2
View Market Depth
Last trade - 15.47pm 04/10/2024 (20 minute delay) ?
Last
52.0¢
  Change
0.005 ( 0.97 %)
Open High Low Volume
52.0¢ 52.0¢ 52.0¢ 4802
Last updated 13.56pm 04/10/2024 ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.